![Proteomics and Biomarkers Proteomics and Biomarkers](/1717397/header_image-1700755057.jpg?t=eyJ3aWR0aCI6ODQ4LCJmaWxlX2V4dGVuc2lvbiI6ImpwZyIsIm9ial9pZCI6MTcxNzM5N30%3D--8fd72adb2244a78867c889b94680942af567e071)
Proteomics and Biomarkers
Research in our laboratory centers on the identification of biosignatures for psychiatric disorders and the response towards antidepressant drugs. Sensitive, high-throughput proteomics and metabolomics platforms are used for data generation providing a rich source for in silico pathway analyses. Our ultimate goal is to complement imprecise DSM-based clinical parameters with molecular biosignatures to improve patient diagnosis, stratification and treatment. Towards this objective we collaborate with clinician scientists at our Institute and elsewhere exploring and mining a variety of specimen sources for biomarkers.
Bild: iStock_ipopba